Log In
Print this Print this

long-acting beta interferon (BBT-032)

  Manage Alerts
Collapse Summary General Information
Company Bolder BioTechnology Inc.
DescriptionLong-acting interferon (IFN) beta analog
Molecular Target Interferon (IFN) beta
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today